Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study

NCT04385069 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04385069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study
Lead sponsor
University College, London
Phase
Observational
Overall status
Unknown status
Start date
April 16, 2020
Completion date
July 5, 2020
Enrollment
500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cov-hi, covid-19, covid-19 (cov) hyperinflammatory (hi) syndrome